Neurologic manifestations in mucopolysaccharidoses

Mucopolysaccharidoses (MPS) are progressive multisystem lysosomal storage diseases caused by defective catabolism of complex molecules, namely the glycosaminoglycans and their consequent accumulation in tissues. Of the 7 clinical types representing 11 different enzyme deficiencies, only MPS III (San...

Full description

Saved in:
Bibliographic Details
Published inArchives de pédiatrie : organe officiel de la Société française de pédiatrie Vol. 21 Suppl 1; pp. S14 - S21
Main Author Héron, B
Format Journal Article
LanguageFrench
Published France 01.06.2014
Subjects
Child
Humans
Mucopolysaccharidoses - complications
Mucopolysaccharidoses - diagnosis
Mucopolysaccharidoses - therapy
Nervous System Diseases - diagnosis
Nervous System Diseases - etiology
Nervous System Diseases - therapy
Online AccessGet full text

Cover

More Information
Summary:Mucopolysaccharidoses (MPS) are progressive multisystem lysosomal storage diseases caused by defective catabolism of complex molecules, namely the glycosaminoglycans and their consequent accumulation in tissues. Of the 7 clinical types representing 11 different enzyme deficiencies, only MPS III (Sanfilippo syndromes A, B, C and D) and severe forms of MPS I (Hurler's syndrome), MPS II (severe Hunter syndrome) and MPS VII (severe Sly syndrome) give rise to progressive cerebral disease. Neurosensory complications (hearing impairment, retinopathy and optic atrophy) can also occur in some types. Carpal (or even tarsal) tunnel syndrome is a common complication of the MPS, except for MPS III and MPS IV. Hydrocephalus due to abnormal circulation or resorption of cerebrospinal fluid, chronic spinal compression may occur as complications of MPS I, II and VII and also in MPS IV and VI. Atlanto-axial instability may be observed in type IV and I.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1769-664X
DOI:10.1016/S0929-693X(14)72254-7